Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Accounts Payables (2019 - 2025)

Cresco Labs' Accounts Payables history spans 7 years, with the latest figure at $16.5 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 21.16% year-over-year to $16.5 million; the TTM value through Dec 2025 reached $16.5 million, up 21.16%, while the annual FY2025 figure was $16.5 million, 21.16% up from the prior year.
  • Accounts Payables reached $16.5 million in Q4 2025 per CRLBF's latest filing, up from $13.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $32.3 million in Q4 2021 to a low of $13.7 million in Q4 2024.
  • Average Accounts Payables over 5 years is $23.6 million, with a median of $27.6 million recorded in 2023.
  • Peak YoY movement for Accounts Payables: surged 38.94% in 2021, then plummeted 50.52% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $32.3 million in 2021, then dropped by 12.97% to $28.1 million in 2022, then decreased by 1.8% to $27.6 million in 2023, then tumbled by 50.52% to $13.7 million in 2024, then increased by 21.16% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Accounts Payables are $16.5 million (Q4 2025), $13.7 million (Q4 2024), and $27.6 million (Q4 2023).